MARGENZA
Active substance: Margetuximab
INJECTION, SOLUTION, CONCENTRATE · MARGETUXIMAB 25 mg/mL
United StatesActive
Marketing holder: TerSera Therapeutics LLC
Verified 2026-10-09 · openFDA NDC
- Source: openFDA NDC
- Countries with the substance registered: 1
Composition
- MARGETUXIMAB · 25 mg/mL
Import and control
Control by country
- United Statesprescription only
Source: openFDA NDC · record 01a12092-851c-7f53-a7de-4a6012dc53bc,01a12099-eb12-7a88-a58f-4b9487214550;count=2 · valid from 2026-10-09 · verified 2026-10-09
Registration
- Registration number
- 70720-022
- Registration status
- Active
- Dispensing
- Prescription only
- Route
- INTRAVENOUS
Sources
- product · openFDA NDC · 70720-022 · Verified 2026-10-09 · open in source
- registration_status · openFDA NDC · 70720-022 · Verified 2026-10-09 · open in source
- ingredients.0 · openFDA NDC · 70720-022 · Verified 2026-10-09 · open in source